Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.
2.

Measurements of iron absorption from prenatal multivitamin--mineral supplements.

Seligman PA, Caskey JH, Frazier JL, Zucker RM, Podell ER, Allen RH.

Obstet Gynecol. 1983 Mar;61(3):356-62.

PMID:
6823378
4.

Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction.

Ambrose PG, Bhavnani SM, Cirincione BB, Piedmonte M, Grasela TH.

J Antimicrob Chemother. 2003 Sep;52(3):435-40. Epub 2003 Aug 13.

5.

Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.

Krishna G, Kisicki JC, Olsen S, Grasela DM, Wang Z.

Pharmacotherapy. 2007 Jul;27(7):963-9.

PMID:
17594201
6.

Adverse reaction to a dietary supplement in an elderly patient.

Sleeper RB, Kennedy SM.

Ann Pharmacother. 2003 Jan;37(1):83-6.

PMID:
12503940
7.

Severe hyperglycemia during renally adjusted gatifloxacin therapy.

Blommel AL, Lutes RA.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1349-52. Epub 2005 Jun 7.

PMID:
15941822
8.

Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.

Lode H, Magyar P, Muir JF, Loos U, Kleutgens K; International Gatifloxacin Study Group.

Clin Microbiol Infect. 2004 Jun;10(6):512-20.

10.

Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.

Costello P, Bakri SJ, Beer PM, Singh RJ, Falk NS, Peters GB, Melendez JA.

Retina. 2006 Feb;26(2):191-5.

PMID:
16467677
12.

Possible gatifloxacin-induced hyperglycemia.

Donaldson AR, Vandiver JR, Finch CK.

Ann Pharmacother. 2004 Apr;38(4):602-5. Epub 2004 Feb 24.

PMID:
14982977
13.

Iron in prenatal multivitamin/multimineral supplements. Bioavailability.

Dawson EB, Dawson R, Behrens J, DeVora MA, McGanity WJ.

J Reprod Med. 1998 Feb;43(2):133-40.

PMID:
9513875
14.

Nutrient intake from multivitamin/mineral supplements is similar among users from five ethnic groups: the Multiethnic Cohort Study.

Park SY, Murphy SP, Martin CL, Kolonel LN.

J Am Diet Assoc. 2008 Mar;108(3):529-33. doi: 10.1016/j.jada.2007.12.011.

PMID:
18313435
15.

Gatifloxacin-induced hyperglycemia: a case report and summary of the current literature.

Yip C, Lee AJ.

Clin Ther. 2006 Nov;28(11):1857-66. Review.

PMID:
17213006
16.

Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters.

Winkler P, de Vrese M, Laue Ch, Schrezenmeir J.

Int J Clin Pharmacol Ther. 2005 Jul;43(7):318-26.

PMID:
16035374
17.

Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.

Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D.

Int J Antimicrob Agents. 2004 Jun;23(6):596-605.

PMID:
15194131
19.

Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.

Sher L, Arguedas A, Husseman M, Pichichero M, Hamed KA, Biswas D, Pierce P, Echols R.

Pediatr Infect Dis J. 2005 Apr;24(4):301-8.

PMID:
15818288
20.

Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.

LeBlanc M, Bélanger C, Cossette P.

Pharmacotherapy. 2004 Jul;24(7):926-31.

PMID:
15303456
Items per page

Supplemental Content

Write to the Help Desk